Citizens Financial Group Inc RI lifted its stake in shares of Humana Inc (NYSE:HUM) by 23.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 450 shares of the insurance provider’s stock after buying an additional 84 shares during the quarter. Citizens Financial Group Inc RI’s holdings in Humana were worth $115,000 at the end of the most recent reporting period.
Several other institutional investors also recently made changes to their positions in the company. Mackay Shields LLC lifted its stake in Humana by 1.0% during the third quarter. Mackay Shields LLC now owns 27,457 shares of the insurance provider’s stock worth $7,020,000 after purchasing an additional 280 shares during the last quarter. IFM Investors Pty Ltd lifted its stake in Humana by 48.3% in the third quarter. IFM Investors Pty Ltd now owns 14,792 shares of the insurance provider’s stock valued at $3,782,000 after buying an additional 4,815 shares during the last quarter. Wright Investors Service Inc. purchased a new stake in Humana in the third quarter valued at approximately $688,000. Wetherby Asset Management Inc. lifted its stake in Humana by 10.5% in the third quarter. Wetherby Asset Management Inc. now owns 4,606 shares of the insurance provider’s stock valued at $1,178,000 after buying an additional 437 shares during the last quarter. Finally, BB&T Corp lifted its stake in Humana by 4.7% in the third quarter. BB&T Corp now owns 1,423 shares of the insurance provider’s stock valued at $364,000 after buying an additional 64 shares during the last quarter. 92.93% of the stock is owned by institutional investors and hedge funds.
HUM has been the subject of a number of research reports. Canaccord Genuity reiterated a “buy” rating on shares of Humana in a research note on Monday, October 21st. BMO Capital Markets cut Humana from an “outperform” rating to a “market perform” rating and reduced their price objective for the company from $345.00 to $290.00 in a research note on Monday, September 30th. ValuEngine upgraded Humana from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. Piper Jaffray Companies boosted their price objective on Humana from $315.00 to $341.00 and gave the company an “overweight” rating in a research note on Thursday, August 1st. Finally, Mizuho initiated coverage on Humana in a research note on Thursday, October 17th. They issued a “buy” rating and a $316.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and sixteen have given a buy rating to the stock. Humana currently has a consensus rating of “Buy” and a consensus price target of $333.30.
NYSE:HUM opened at $304.94 on Thursday. The firm has a market cap of $40.12 billion, a P/E ratio of 20.96, a PEG ratio of 1.28 and a beta of 0.85. The company has a current ratio of 1.75, a quick ratio of 1.75 and a debt-to-equity ratio of 0.37. The stock’s 50 day simple moving average is $275.88 and its 200-day simple moving average is $270.18. Humana Inc has a 12-month low of $225.65 and a 12-month high of $355.88.
Humana (NYSE:HUM) last released its earnings results on Wednesday, November 6th. The insurance provider reported $5.03 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $4.58 by $0.45. The business had revenue of $16.24 billion for the quarter, compared to analyst estimates of $16.15 billion. Humana had a return on equity of 22.47% and a net margin of 4.13%. The company’s revenue for the quarter was up 14.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.58 earnings per share. Research analysts forecast that Humana Inc will post 17.67 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.72%. The ex-dividend date is Monday, December 30th. Humana’s payout ratio is currently 15.12%.
In other news, insider Brian P. Leclaire sold 7,239 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $289.70, for a total value of $2,097,138.30. Following the transaction, the insider now owns 12,994 shares of the company’s stock, valued at $3,764,361.80. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.54% of the company’s stock.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Further Reading: Does the discount rate affect the economy?
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.